# FDA Inspection 1058583 - Megafine Pharma (P) Limited - June 15, 2018

Source: https://www.globalkeysolutions.net/records/fda_inspections/megafine-pharma-p-limited/5f17d11f-808d-4615-843d-37ed847ce74a
Source feed: FDA_Inspections

> FDA Inspection 1058583 for Megafine Pharma (P) Limited on June 15, 2018. Classification: Official Action Indicated (OAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1058583
- Company Name: Megafine Pharma (P) Limited
- Inspection Date: 2018-06-15
- Classification: Official Action Indicated (OAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1207908 - 2023-05-12](https://www.globalkeysolutions.net/records/fda_inspections/megafine-pharma-p-limited/893a79ec-a5e0-4761-81fc-eb0afaf7a88c)
- [FDA Inspection 1121027 - 2020-02-21](https://www.globalkeysolutions.net/records/fda_inspections/megafine-pharma-p-limited/5f85e976-c20c-4539-8fd3-024d158e4a23)
- [FDA Inspection 988000 - 2016-09-23](https://www.globalkeysolutions.net/records/fda_inspections/megafine-pharma-p-limited/44d0f909-d360-496d-a78c-eb1dd8497734)
- [FDA Inspection 828506 - 2013-03-13](https://www.globalkeysolutions.net/records/fda_inspections/megafine-pharma-p-limited/bc910809-b46a-4e10-bcd8-e6930da6f8b3)

Company: https://www.globalkeysolutions.net/companies/megafine-pharma-p-limited/47f3a083-30b0-4f15-ac09-3f99d5e75442

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c